Tower Research Capital LLC (Trc) Evelo Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
BUY
$0.17 - $1.57 $4,591 - $42,400
27,007 Added 507.65%
32,327 $6,000
Q4 2022

Feb 10, 2023
BUY
$1.44 - $48.2 $50 - $1,687
35 Added 0.66%
5,320 $9,000
Q3 2022

Nov 10, 2022
SELL
$1.86 - $41.8 $1,240 - $27,880
-667 Reduced 11.21%
5,285 $11,000
Q2 2022

Aug 15, 2022
BUY
$1.46 - $3.55 $4,517 - $10,983
3,094 Added 108.26%
5,952 $13,000
Q1 2022

May 12, 2022
SELL
$2.66 - $6.63 $10,163 - $25,333
-3,821 Reduced 57.21%
2,858 $10,000
Q4 2021

Feb 14, 2022
BUY
$6.07 - $12.0 $12,856 - $25,416
2,118 Added 46.44%
6,679 $40,000
Q3 2021

Nov 15, 2021
BUY
$6.79 - $13.9 $14,754 - $30,204
2,173 Added 91.0%
4,561 $32,000
Q2 2021

Aug 16, 2021
BUY
$9.43 - $16.6 $4,403 - $7,752
467 Added 24.31%
2,388 $33,000
Q1 2021

May 17, 2021
SELL
$9.71 - $18.6 $14,642 - $28,048
-1,508 Reduced 43.98%
1,921 $21,000
Q4 2020

Feb 16, 2021
SELL
$3.91 - $12.28 $52,214 - $163,987
-13,354 Reduced 79.57%
3,429 $41,000
Q3 2020

Nov 16, 2020
BUY
$3.81 - $5.73 $52,513 - $78,976
13,783 Added 459.43%
16,783 $88,000
Q2 2020

Aug 13, 2020
BUY
$3.53 - $6.12 $8,507 - $14,749
2,410 Added 408.47%
3,000 $15,000
Q1 2020

May 15, 2020
SELL
$3.21 - $7.06 $3,636 - $7,998
-1,133 Reduced 65.76%
590 $2,000
Q4 2019

Feb 07, 2020
SELL
$3.81 - $7.45 $8,892 - $17,388
-2,334 Reduced 57.53%
1,723 $7,000
Q3 2019

Nov 05, 2019
BUY
$5.45 - $8.8 $21,592 - $34,865
3,962 Added 4170.53%
4,057 $24,000
Q2 2019

Aug 13, 2019
SELL
$6.52 - $9.42 $30,350 - $43,850
-4,655 Reduced 98.0%
95 $1,000
Q1 2019

May 14, 2019
BUY
$7.5 - $15.31 $20,070 - $40,969
2,676 Added 129.03%
4,750 $38,000
Q4 2018

Feb 14, 2019
SELL
$7.29 - $13.01 $13,537 - $24,159
-1,857 Reduced 47.24%
2,074 $27,000
Q3 2018

Nov 13, 2018
BUY
$11.93 - $14.76 $26,401 - $32,663
2,213 Added 128.81%
3,931 $48,000
Q2 2018

Aug 15, 2018
BUY
$11.39 - $16.26 $19,568 - $27,934
1,718 New
1,718 $20,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email